In recent research, Benefits and Barriers to Adopting Advanced Manufacturing Technology in the Pharmaceutical Industry, our team at the API Innovation Center discovered that regulatory uncertainty, particularly in navigating FDA approval processes for facilities transitioning from batch manufacturing, was mentioned by 78% of participants as a major barrier.
As an industry, what do you think we can do to help reduce this uncertainty? Do you feel this challenge as well?